Home > Boards > US Listed > Biotechs > Actinium Pharmaceuticals, Inc. (ATNM)

ATNM Daily Chart:

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Golden_Cross Member Profile
Member Level 
Followed By 728
Posts 31,561
Boards Moderated 46
Alias Born 10/05/05
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 6/7/2019 5:05:42 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/10/2019 4:58:07 PM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 5/10/2019 4:51:31 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/18/2019 5:25:44 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 4/18/2019 5:08:23 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 4/18/2019 11:52:54 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 4/17/2019 4:18:04 PM
Annual Report (10-k) Edgar (US Regulatory) - 3/15/2019 5:05:11 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/12/2019 5:26:30 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/7/2019 4:52:38 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/21/2019 4:48:55 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/14/2019 2:20:32 PM
Actinium Initiates Novel Phase 1/2 Combination Trial of Actimab-A and Venetoclax PR Newswire (US) - 2/5/2019 8:00:00 AM
Actinium Initiates Second Dosing Cohort of Novel Combination Trial with Actimab-A and CLAG-M Salvage Regimen at Medical Colle... PR Newswire (US) - 2/4/2019 8:00:00 AM
Actinium Pharmaceuticals to Host Key Opinion Leader Breakfast on Targeted Conditioning for Bone Marrow Transplant and CAR-T o... PR Newswire (US) - 1/29/2019 8:00:00 AM
Actinium Pharmaceuticals, Inc. to Present at Noble Capital Markets' 15th Annual Investor Conference PR Newswire (US) - 1/25/2019 8:00:00 AM
Actinium Pharmaceuticals Appoints Accomplished Industry Executive Cynthia Pussinen as Executive Vice President of Technical O... PR Newswire (US) - 1/23/2019 8:00:00 AM
Actinium Successfully Completes First Module of Collaborative Research Program with Astellas; Second Module Initiated PR Newswire (US) - 1/17/2019 8:00:00 AM
Actinium Pharmaceuticals Appoints Qing Liang, PhD, DABR as Vice President, Head of Radiation Sciences to Further Innovation f... PR Newswire (US) - 1/16/2019 8:00:00 AM
Actinium Pharmaceuticals, Inc. to Present at the 2019 Biotech Showcase™ in San Francisco PR Newswire (US) - 1/3/2019 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/28/2018 5:11:58 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 12/28/2018 5:10:38 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/26/2018 5:03:31 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/21/2018 4:59:01 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/10/2018 4:15:25 PM
Golden_Cross Member Level  Tuesday, 04/02/19 04:03:16 AM
Re: None
Post # of 1650 
ATNM Daily Chart:

\

Lets exchange follow marks and share market moving information today!
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist